Jump Financial, LLC

Position in REPL — Replimune Group, Inc.

CIK 1831577 Chicago, IL

Position in REPL

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$798,498

-$2,086,815 QoQ

Shares Held

104,379

-64.8% QoQ

Ownership

0.124%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Jump Financial, LLC holds $252,934,314 across 133 Biotechnology names. REPL ranks #68 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	206,675	$15,519,225
2	APLS	Apellis Pharmaceuticals, Inc.	291,488	$11,726,562
3	SRPT	Sarepta Therapeutics, Inc.	507,828	$11,050,335
4	DAWN	Day One Biopharmaceuticals, Inc.	497,365	$10,663,505
5	RARE	Ultragenyx Pharmaceutical Inc.	504,143	$10,561,795
6	LEGN	Legend Biotech Corp	516,633	$9,345,890
7	XENE	Xenon Pharmaceuticals Inc.	155,776	$9,058,374
8	BNTX	BioNTech SE	79,189	$7,038,317

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$798,498	104,379	-64.8%	Shares	Defined	2026-05-14
2025-12-31	$2,885,313	296,843	+21.8%	Shares	Defined	2026-02-17
2025-09-30	$1,021,383	243,767	+241.2%	Shares	Defined	2025-11-13
2024-12-31	$865,174	71,443	+95.5%	Shares	Defined	2025-02-13
2024-09-30	$400,434	36,536	-70.9%	Shares	Defined	2024-11-14
2024-06-30	$1,129,050	125,450	+499.1%	Shares	Defined	2024-11-14
2024-03-31	$171,087	20,941	-49.6%	Shares	Sole	2024-05-13
2022-12-31	$1,130,649	41,568	+205.6%	Shares	Sole	2023-02-14
2022-09-30	$234,872	13,600	+19.3%	Shares	Sole	2022-11-07
2022-06-30	$199,237	11,398	-67.8%	Shares	Sole	2022-08-09
2022-03-31	$601,092	35,400	+207.4%	Shares	Sole	2022-05-12
2020-12-31	$439,335	11,516	—	Shares	Sole	2021-02-12
No filing history on record for this holder in this stock.